Federal Register / Vol. 87, No. 79 / Monday, April 25, 2022 / Notices 24305 

undertaken to implement or enforce the 

COVID–19 vaccination requirement. 

Approved: April 20, 2022. 

Emory Rounds, 

Director, U.S. Office of Government Ethics. 

[FR Doc. 2022–08754 Filed 4–22–22; 8:45 am] 

BILLING CODE 6345–03–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–22–0978] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘Emerging 

Infections Program (EIP)’’ to the Office 

of Management and Budget (OMB) for 

review and approval. CDC previously 

published a ‘‘Proposed Data Collection 

Submitted for Public Comment and 

Recommendations’’ notice on January 

31, 2022, to obtain comments from the 

public and affected agencies. CDC did 

not receive comments related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Emerging Infections Program (OMB 

Control No. 0920–0978, Exp. 4/30/ 

2022)—Revision—National Center for 

Emerging and Zoonotic Infectious 

Diseases (NCEZID), Centers for Disease 

Control and Prevention (CDC). 

Background and Brief Description 

The Emerging Infections Programs 

(EIPs) are population-based centers of 

excellence established through a 

network of state health departments 

collaborating with academic 

institutions; local health departments; 

public health and clinical laboratories; 

infection control professionals; and 

healthcare providers. EIPs assist in 

local, state, and national efforts to 

prevent, control, and monitor the public 

health impact of infectious diseases. 

Activities of the EIPs fall into the 

following general categories: (1) Active 

surveillance; (2) applied public health 

epidemiologic and laboratory activities; 

(3) implementation and evaluation of 

pilot prevention/intervention projects; 

and (4) flexible response to public 

health emergencies. These activities are 

designed to: (1) Address issues that the 

EIP network is particularly suited to 

investigate; (2) maintain sufficient 

flexibility for emergency response and 

new problems as they arise; (3) develop 

and evaluate public health interventions 

to inform public health policy and 

treatment guidelines; (4) incorporate 

training as a key function; and (5) 

prioritize projects that lead directly to 

the prevention of disease. 

A Revision is being submitted to make 

existing collection instruments clearer 

and to add several new forms 

specifically surveying laboratory 

practices. These forms will allow the 

EIP to better detect, identify, track 

changes in laboratory testing 

methodology, gather information about 

laboratory utilization in the EIP 

catchment area to ensure that all cases 

are being captured, and survey EIP staff 

to evaluate program quality. 

Total estimated burden is 61,956 

hours. There is no cost to respondents 

other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

State Health Department.ABCs Case Report Form ................................................................... 10 809 20/60 

ABCs Invasive Pneumococcal Disease in Children and Adults Case 

Report Form.

10 127 10/60 

ABCs H.influenzae Neonatal Sepsis Expanded Surveillance Form .. 10 6 10/60 

ABCs Severe GAS Infection Supplemental Form .............................. 10 136 20/60 

ABCs Neonatal Infection Expanded Tracking Form .......................... 10 37 20/60 

FoodNet Campylobacter ..................................................................... 10 970 21/60 

FoodNet Cyclospora ........................................................................... 10 42 10/60 

FoodNet Listeria monocytogenes ....................................................... 10 16 20/60 

FoodNet Salmonella ........................................................................... 10 855 21/60 

FoodNet Shiga toxin producing E. coli ............................................... 10 290 20/60 

FoodNet Shigella ................................................................................ 10 234 10/60 

FoodNet Vibrio .................................................................................... 10 46 10/60 

FoodNet Yersinia ................................................................................ 10 55 10/60 


khammond on DSKJM1Z7X2PROD with NOTICES
24306 Federal Register / Vol. 87, No. 79 / Monday, April 25, 2022 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

FoodNet Hemolytic Uremic Syndrome Case Report Form ................ 10 10 1 

FoodNet Clinical Laboratory Practices and Testing Volume ............. 10 70 20/60 

FluSurv-NET Influenza Hospitalization Surveillance Network Case 

Report Form.

10 764 25/60 

FluSurv-NET Influenza Hospitalization Surveillance Project Vaccination Phone Script Consent Form (English).10 333 5/60 

FluSurv-NET Influenza Hospitalization Surveillance Project Vaccination Phone Script (Spanish).10 333 5/60 

Influenza Hospitalization Surveillance Project Provider Vaccination 

History Fax Form (Children/Adults).

10 333 5/60 

FluSurv-NET Laboratory Survey ........................................................ 10 16 10/60 

HAIC—MuGSI Case Report Form for Carbapenem-resistant 

Enterobacteriaceae (CRE) and Acinetobacter baumannii (CRAB).

10 500 28/60 

HAIC—MuGSI Extended-Spectrum Beta-Lactamase-Producing 

Enterobacteriaceae (ESBL/iEC).

10 4200 25/60 

HAIC—Invasive Methicillin-resistant Staphylococcus aureus 

(MRSA) Infection Case Report Form.

10 340 28/60 

HAIC—Invasive Methicillin-sensitive Staphylococcus aureus 

(MSSA) Infection Case Report Form.

10 584 28/60 

HAIC—CDI Case Report and Treatment Form ................................. 10 1650 38/60 

HAIC Candidemia Case Report ......................................................... 10 200 30/60 

HAIC—Annual Survey of Laboratory Testing Practices for C. 

difficile Infections.

10 16 19/60 

HAIC—CDI Annual Surveillance Officers Survey .............................. 10 1 15/60 

HAIC—Emerging Infections Program C. difficile Surveillance Nursing Home Telephone Survey (LTCF).10 45 5/60 

HAIC—Invasive Staphylococcus aureus Laboratory Survey ............. 10 11 20/60 

HAIC—Invasive Staphylococcus aureus Supplemental Surveillance 

Officers Survey.

10 1 10/60 

HAIC—Laboratory Testing Practices for Candidemia Questionnaire 10 20 12/60 

HAIC MuGSI CA CP–CRE Health interview (new) ............................ 100 10 30/60 

HAIC MuGSI Supplemental Surveillance Officer Survey (new) ........ 10 1 15/60 

HAIC Death Ascertainment Variables ................................................ 10 8 1440/60 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–08704 Filed 4–22–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Meeting of the Community Preventive 

Services Task Force 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC) within 

the Department of Health and Human 

Services (HHS) announces the next 

meeting of the Community Preventive 

Services Task Force (CPSTF) on June 

8–9, 2022. 

DATES: The meeting will be held on 

Wednesday, June 8, 2022, from 10:00 

a.m. to 6:00 p.m. EDT, and Thursday, 

June 9, 2022, from 10:00 a.m. to 6:00 

p.m. EDT. 

ADDRESSES: The meeting will be held 

virtually via web conference. 

FOR FURTHER INFORMATION CONTACT: 

Arielle Arnold, Office of the Associate 

Director for Policy and Strategy; Centers 

for Disease Control and Prevention, 

1600 Clifton Road NE, MS V25–5, 

Atlanta, GA 30329. Telephone: 

(404)498–4512; Email: CPSTF@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Meeting Accessibility: The CPSTF 

meeting will be held virtually via web 

conference. 

CDC will send web conference 

information to registrants upon receipt 

of their registration. All meeting 

attendees must register by June 1, 2022 

to receive the web conference 

information for meeting. CDC will email 

web conference information from the 

CPSTF@cdc.gov mailbox. 

To register for the meeting, 

individuals should send an email to 

CPSTF@cdc.gov and include the 

following information: Name, title, 

organization name, organization 

address, phone, and email. 

Public Comment: Individuals who 

would like to make public comments 

during the June meeting must state their 

desire to do so with their registration 

and provide their name and 

organizational affiliation and the topic 

to be addressed (if known). The 

requestor will receive instructions for 

the public comment process for this 

virtual meeting after the request is 

received. A public comment period 

follows the CPSTF’s discussion of each 

systematic review and will be limited, 

up to three minutes per person. Public 

comments will become part of the 

meeting summary. 

Background on the CPSTF: The 

CPSTF is an independent, nonfederal 

panel whose members are appointed by 

the CDC Director. CPSTF members 

represent a broad range of research, 

practice, and policy expertise in 

prevention, wellness, health promotion, 

and public health. The CPSTF was 

convened in 1996 by HHS to identify 

community preventive programs, 

services, and policies that increase 

health, longevity, save lives and dollars, 

and improve Americans’ quality of life. 

CDC is mandated to provide ongoing 


khammond on DSKJM1Z7X2PROD with NOTICES